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This discussion will highlight the following 9 specific points that related to 
metabolic acidosis caused by various toxins. The current recommendation 
suggests that alcohol dehydrogenase inhibitor fomepizole is preferred to ethanol in 
treatment of methanol and ethylene glycol poisoning, but analysis of the enzyme 
kinetics indicates that ethanol is a better alternative. In the presence of a modest 
increase in serum osmolal gap (<30 mOsm/L), the starting dose of ethanol 
should be far less than the usual recommended dose. One can take advantage 
of the high vapor pressure of methanol in the treatment of methanol poisoning 
when hemodialysis is not readily available.  Profuse sweating with increased 
water ingestion can be highly effective in reducing methanol levels. Impaired 
production of ammonia by the proximal tubule of the kidney plays a major role 
in the development of metabolic acidosis in pyroglutamic acidosis. Glycine, not 
oxalate, is the main final end product of ethylene glycol metabolism. Metabolism 
of ethylene glycol to oxalate, albeit important clinically, represents less than 1% 
of ethylene glycol disposal. Urine osmolal gap would be useful in the diagnosis 
of ethylene glycol poisoning, but not in methanol poisoning. Hemodialysis is 
important in the treatment of methanol poisoning and ethylene glycol poisoning 
with renal impairment, with or without fomepizole or ethanol treatment. Severe 
leucocytosis is a highly sensitive indicator of ethylene glycol poisoning. Uncoupling 
of oxidative phosphorylation by salicylate can explain most of the manifestations 
of salicylate poisoning. 
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The following contains short discussions on certain 
aspects of toxin-induced metabolic acidosis, which 
represent this author’s unconventional views on them or 
highlight some underemphasized or misunderstood aspects 
of these disorders.
Which is better: ethanol or fomepizole?
The current consensus is that fomepizole is better than 
ethanol for treatment of methanol and ethylene glycol 
poisoning, mainly on the basis that it has fewer side 
effects and is easier to use
1, 2), although that the cost of 
fomepizole, at $1,000 for a 1.5 g ampule or an average 
cost of about $4,000 per patient, is much greater than 
that of ethanol. The comparison of side effects is based on 
the usual recommended dose of ethanol, which is set to 
maintain plasma levels at 100 mg/dL or higher until plasma 
methanol or ethylene glycol levels decrease below 20 mg/
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dL. At the recommended dose of ethanol, many patients, 
especially those not accustomed to ethanol drinking, 
would indeed be severely intoxicated, and develop side 
effects. 
The recommended maintenance level of plasma ethanol 
for treatment of methanol and ethylene glycol poisoning 
has not been determined either by careful theoretical 
analysis or by empirical evidence
3). Ethanol is used to treat 
intoxication of methanol and ethylene glycol because 
hepatic ethanol dehydrogenase is the main enzyme for 
their metabolism, but the enzyme has much greater affinity 
to ethanol than to either chemical. Since toxic effects of 
these alcohols result from production of their metabolites, 
administration of ethanol, being the preferred substrate of 
the enzyme, prevents metabolism of toxic alcohols. In fact, 
Km values of ethylene glycol and methanol are about 40– 
50 fold greater than that of ethanol
4, 5). Km for ethanol is 5.2 
mg/dL, while those for methanol and ethylene glycol are 
171.7 and 275.2 mg/dL respectively
4, 5). 
Patients with ethylene glycol and methanol poisoning 
have varying plasma levels of the toxic alcohols at the time 
of admission to the hospital. For example, in case reports 
by Ekins et al., the initial plasma levels ranged between 46 
mg/dL and 377 mg/dL
6). Similarly, patients of Pappas and 
Silverman had plasma methanol levels between 42 and 
464 mg/dL
7). Yet, everyone was treated with ethanol at 
the same plasma level, 100 mg/dL. Furthermore, during 
hemodialysis, plasma levels of toxic alcohols decrease 
rapidly, but it is recommended to maintain the same 
plasma levels of ethanol. Davis et al. treated a patient with 
a plasma ethylene glycol level of 888 mg/dL (143 mmol/L)
8), 
with the same ethanol dose. Schwerk et al. treated a patient 
with a even higher level of ethylene glycol, 3,900 mg/dL 
(629 mmol/L), with the standard dose of ethanol
9). The 
highest concentration of plasma methanol intoxication was 
the case reported by Martens et al.
10), and the patient had 
a plasma methanol of 921.2 mg/dL, and was again treated 
with the standard dose of ethanol. 
Indeed, it has been shown in dog experiment that plasma 
level of ethanol of 35 mg/dL is as effective in preventing 
metabolism of ethylene glycol as 140 mg/dL of ethanol
11). 
At the plasma level of ethanol at 35 mg/dL, most people 
would not be too symptomatic. It is not even known 
whether 35 mg/dL of ethanol is the minimum necessary 
level for most patients with toxic alcohol poisoning. If 
a patient with a methanol level of 961.3 mg/dL can be 
effectively treated with 100 mg/dL of ethanol, it would 
seem reasonable to assume that a patient with methanol 
intoxication at 1/5 of the plasma level should be effectively 
treated at 1/5 the usual dose of ethanol, 20 mg/dL (6.3 
mmol/L). The concentration of 20 mg/dL is still more than 
5 times the Km value of ethanol for alcohol dehydrogenase, 
and at this concentration ethanol metabolism would occur 
at about 83% of the maximal capacity. In the management 
of ethanol and ethylene glycol poisoning, one can quickly 
assess the approximate plasma level of the toxic alcohols by 
the measurement of osmolal gap. If the gap is less than 50 
mOsm/L, one can safely initiate the ethanol treatment with 
maintenance of plasma level at about 20 mg/dL. This level 
that can be easily achieved by drinking a half glass of wine 
or a can of beer. At higher level of toxins, one can start 
ethanol therapy at a proportionately higher rate, but the 
rate can be safely reduced once hemodialysis is initiated. 
I might add that complete inhibition of metabolism of 
methanol and ethylene glycol is not necessary; but the aim 
should be to reduce its metabolism sharply, e.g. to less than 
20 mg/dL. The body can handle the small load of these 
metabolites, which are normally produced in the human 
body in small quantities.
On the basis of the same principle, it would not be 
necessary to maintain the same plasma concentration 
of fomepizole (8.6–24.6 mg/L; 100–300 μmol/L) for 
all patients with methanol or ethylene glycol poisoning 
regardless of the plasma levels of the toxins
12-15). Velez et 
al. treated a patient with an ethylene glycol level of 706 
mg/dL with fomepizole at the standard dose, while others 
have treated patients with plasma ethylene glycol levels 
of under 50 mg/dL with the same dose. Since both the 
drug and toxins are competitive inhibitors of the toxic 
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toxic alcohols would demand commensurate reductions 
in fomepizole. The current recommendation calls for 
increasing the fomepizole dose during hemodialysis on 
the rationale that the drug is rapidly removed by dialysis. 
However, as the drug is removed, the toxic alcohols are 
also removed, and hence competition is lessened also. 
Thus, increases in fomepizole dosage would be necessary 
during hemodialysis. 
There is evidence that H-2 blockers inhibit alcohol 
dehydrogenase and would inhibit the metabolism of 
methanol
16). Indeed, ranitidine has been used to treat 
methanol toxicity in rats
17). Perhaps, this class of drugs 
could turn out to be a much cheaper alternative to 
fomepizole in treating methanol poisoning. On the other 
hand, inhibition of ethylene glycol by H-2 blockers is not as 
effective.
Sauna bath and exercise for methanol intoxication
Near complete inhibition of alcohol dehydrogenase to 
prevent metabolism of methanol either with ethanol or 
fomepizole results in a very long half life of methanol, 
43 hours
18). The concentration of methanol in urine is 
equal to that in plasma, but there is some extra-renal loss 
through insensible perspiration. Hemodialysis is the best 
way to remove methanol, but the procedure is not always 
available. Forced diuresis can increase the excretion of 
methanol somewhat; excreting 10 L of urine per day by a 
person with 40 L of total body water could remove about 
25% of the methanol in the body in 24 hours. Another 
approach is to increase insensible loss by sauna bath or 
exercise.  This is based on the principle that methanol has 
much higher vapor pressure than water. At 37°C, vapor 
pressure of water is 47 mm Hg, and that for methanol is 
230.5 mm Hg, about 5 times that of water. Loss of 1 L of 
water by evaporation would have an equivalent methanol 
clearance of 5 L, or 83 mL/min. This is not as efficient as 
hemodialysis clearance of methanol, about 200 mL/min, 
but is still quite substantial. 
Leucocytosis in ethylene glycol poisoning: 
possible diagnostic value
Leucocytosis is a consistent finding in ethylene glycol 
poisoning, and usually it is quite severe
19-22). Mydlik et 
al. noted, in his review of the record of 17 patients with 
ethylene glycol poisoning, leucocytosis in all of them
23).  It 
is possible that the leucocytosis is in response to the stress 
of severe metabolic acidosis, but leucocytosis is not always 
found or as severe in metabolic acidosis caused by other 
toxins. The mechanism is unknown, but is tempting to 
speculate that it could be a response to tissue deposits of 
calcium oxalate crystals. Leucocytosis is a common clinical 
manifestation, and is not a specific finding for ethylene 
glycol poisoning, but its universal finding makes it a 
useful diagnostic tool in that one can rule ethylene glycol 
poisoning in the absence of leucocytosis.
Oxalate is not the major endproduct of ethylene 
glycol metabolism
In the discussion of ethylene glycol metabolism, most 
authorities emphasize metabolism of ethylene glycol to 
oxalic acid as the major metabolic pathway
14). It is clear 
that production of oxalic acid is a clinically relevant 
and diagnostically useful pathway of ethylene glycol 
metabolism. Appearance of calcium oxalate crystals in 
urine is almost universal, and deposits of calcium oxalate 
in the tissues including the kidney is well recognized, and 
is implicated as the cause of some of the toxic effects of 
ethylene glycol
24, 25). Oxalate over-production also explains 
hypocalcemia, which is very common in ethylene glycol 
poisoning. However, quantitatively, oxalate is a minor 
byproduct of ethylene glycol poisoning. The immediate 
precursor of oxalate is glyoxylate, which is converted to 
oxalate by the action of lactate dehydrogenase (LDH). The 
most important pathway is conversion to glycine by the 
action of alanine-glyoxylate aminotransferase with vitamin 
B6 as a co-factor
26). The quantitative unimportance of 
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calculates the total extracellular calcium content. At plasma 
calcium of 10 mg/dL (2.5 mmol/L), the amount of total 
calcium in the extracellular fluid (ECF) is about 1,600 mg 
for a person with extracellular volume of 16 L. The lethal 
dose of ethylene glycol is considered to be about 100 mL. 
Since specific gravity is 1.246, the amount is equal to about 
124 g or about 12,414 mg/dL. Conversion of mere 2% of 
these 12,414 mg/dL would chelate the entire calcium pool 
of the ECF compartment. Clearly, the amount of oxalate 
production is much less than 1,800 mg (40 mmol).
Ethanol and fomepizole are not useful in toluene 
and benzyl alcohol poisoning
Ethanol dehydrogenase is a non-specific enzyme with 
many substrates including benzyl alcohol. However, 
either ethanol or fomepizole has been tried or advisable 
to treat benzyl alcohol poisoning. One of the reasons for 
not using ethanol to treat benzyl alcohol poisoning is that 
the main enzyme responsible for metabolism of benzyl 
alcohol in humans is nicotinamide adenine dinucleotide 
phosphate (NADPH)-dependent cytochrome-450 oxidase 
27), not alcohol dehydrogenase. In certain species, alcohol 
dehydrogenase metabolizes benzyl alcohol, but the affinity 
of benzyl alcohol to alcohol dehydrogenase is actually 
greater than ethanol. Furthermore, metabolic endproducts 
of benzyl alcohol, benzoic acid and hippuric acid, do 
not have much harmful effects, but actually may possess 
some beneficial effects. Both acids are the main organic 
acids present in cranberry juice, and are thought to be 
responsible for its antibacterial effects in the prevention of 
urinary tract infection (UTI).
Uncoupling of oxidative phosphorylation is the 
main mechanism of salicylate poisoning
Salicylate poisoning, a major cause of poisoning 
because of its widespread use, has many different clinical 
manifestations, and one unifying mechanism that could 
explain most of the manifestations of salicylate poisoning 
is uncoupling of oxidative phosphorylation. Salicylate is an 
uncoupler
28, 29), and has a chemical structure that is quite 
similar to a better known uncoupler, 2, 4-dinitrophenol.       
Glarborg et al. have shown that uncoupling of oxidative 
phosphorylation occurred at a salicylate concentration 
between 483.4 and 773.5 mg/L
30). Extensive uncoupling 
increases glucose and oxygen consumption, and results 
in adenosine triphosphate (ATP) deficiency. Evidence 
indicates that much of excess glucose utilization occurs 
in the brain. In one case report of salicylate poisoning, 
125 g of glucose had to be infused over 5 hours to treat 
hypoglycemia, indicating that glucose consumption by the 
brain had increased more than five fold
31). There is some 
evidence that salicylate inhibits Krebs cycle
32), but this 
would cause lactic acidosis, not excessive consumption of 
glucose. The following are some of the manifestations of 
salicylate poisoning that can be explained by uncoupling.
1. Fever
Aspirin is an antipyretic, but fever is common in salicylate 
poisoning, and this is explained by excessive glucose 
utilization creating heat.
2. Tinnitus and deafness
ATP deficiency of inner ear due to uncoupling could be 
the cause.
3. Ketoacidosis
This is more common in children and women, and 
is likely to be due to increased production of lipolytic 
hormones in response to central hypoglycemia. Hypo-
glycemia is common in salicylate poisoning
33), and 
sometimes brain glucose is low while plasma glucose is 
normal because of increased utilization of glucose due to 
uncoupling that is most pronounced in the brain
34).  
4. Lactic acidosis
Extensive uncoupling causes deficiency of ATP, which 
increases production of nicotinamide adenine dinucleotide 
(NADH) and lactic acidosis.36      MS Oh  •  Uncoventional Views on Certain Aspects of Toxin-Induced Metabolic Acidosis
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5. Respiratory alkalosis
Respiratory alkalosis is the commonest acid-base disorder 
of salicylate poisoning, and the current explanation is 
that the drug stimulates the respiratory center directly. 
However, one plausible explanation is that increased 
glucose utilization in the brain would increase production 
of CO2 in the brain including the central respiratory center. 
Thus, what appears to be systemic respiratory alkalosis 
could be a normal physiological response to the central 
nervous system (CNS) respiratory acidosis.
Urine osmolal gap for diagnosis of ethylene glycol 
poisoning
Unlike methanol, ethylene glycol is substantially 
concentrated in the urine. Mean renal clearance has been 
measured at 27.5 mL/min with fractional excretion of 
19.8%
35). Similar clearance values were obtained by Harry 
et al.
36). This would mean that for a person who has 2 L of 
urine output, the urinary concentration of ethylene glycol 
would be about 10 times the concentration in the blood. 
A common recommendation for the diagnostic screening 
of methanol and ethylene glycol poisoning is to measure 
serum osmolal gap. However, when concentrations of 
the toxic alcohol levels are not very high, the change in 
serum osmolal gap would be too small to be useful for 
a diagnostic purpose. For example, a concentration of 
ethylene glycol of 50 mg/dL, the generally considered 
to be a clinically significant level, would give a plasma 
osmolal gap of mere 8 mOsm/L. A 10 fold concentration 
in the urine would result in urine osmolal gap of about 80 
mOsm/L, and this would be much easier to detect. One 
concern is that measurement of urine osmolal gap is more 






2+, and then 
include urea, glucose, and creatinine. The predicted urine 





+)×2+urea/2.8+creatinine/11.3+glucose/18. All of these 
tests are readily available in most hospital laboratories with 
the exception of NH4
+ If the NH4
+ measurement is not 
available, one can assume an amount of about 30 mEq/g of 
urine creatinine. 
Urine osmolal gap = Measured Osmolality - Predicted 
Osmolality
This is my theoretical suggestion that has not been tested. 
Perhaps, experiments can be carried out in an animal 
model. 
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